Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Oregon Therapeutics

PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of new anti cancer treatments. The company engages in the development of new cancer drugs from chemical molecules targeting groups of enzymes involved in cell metabolism, enabling cancer patients to get anti cancer drugs for their treatment.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Primary Office
  • Paris
  • France
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Oregon Therapeutics’s full profile, request a free trial.

Oregon Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator 20-Mar-2015 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Oregon Therapeutics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Agoranov Accelerator/Incubator Minority 000 0000 000000 0